The success of Sildenafil initially fueled a boom for pharma, but recent changes present a uncertain scenario for those considering a stake. Off-patent alternatives are reducing revenue, and ongoing litigation add https://kianaukeo861367.thelateblog.com/41525867/viagra-and-the-pharmaceutical-industry-a-volatile-bet